Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07190690 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Study acronym: DestinACSion
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 19 to 20v21
  2. Study sites: 18 to 19v20
  3. Study sites: 17 to 18v19
  4. Study sites: 16 to 17v18
  5. Study sites: 15 to 16v17
Show 15 earlier versionsHide 15 earlier versions
  1. Study sites: 14 to 15v16
  2. Study sites: 13 to 14v15
  3. Study sites: 12 to 13v14
  4. Study sites: 11 to 12v13
  5. Study sites: 10 to 11v12
  6. Study sites: 9 to 10v11
  7. Study sites: 8 to 9v10
  8. Study sites: 7 to 8v9
  9. Study sites: 6 to 7v8
  10. Study sites: 5 to 6v7
  11. Study sites: 4 to 5v6
  12. Study sites: 3 to 4v5
  13. Study sites: 2 to 3v4
  14. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 2 · Start date changed from estimate of Dec 15, 2025 to Dec 19, 2025v3 Show 2 more changesShow less
    • Study sites: 0 to 2
    • Start date changed from estimate of Dec 15, 2025 to Dec 19, 2025
  15. Start date: Oct 15, 2025 to Dec 15, 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the efficacy of the two DES (Drug Eluting Stent) used in terms of device-related adverse events at 12 months after PCI (Percutaneous Coronary Intervention). To compare the clinical safety and efficacy by comparing net clinical events (defined as the combination of ischemic and hemorrhagic events) of the two DES used at 12 months after PCI.
Trial Details
NCT Number NCT07190690
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease
Enrollment 2,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov